Timothy Schmid - Feb 8, 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, MedTech
Signature
Raavi Deol, as attorney-in-fact for Timothy Schmid
Stock symbol
JNJ
Transactions as of
Feb 8, 2024
Transactions value $
-$156,486
Form type
4
Date filed
2/12/2024, 07:24 PM
Previous filing
Nov 2, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +1.96K +21.87% $0.00 10.9K Feb 8, 2024 Direct F1
transaction JNJ Common Stock Tax liability -$156K -1K -9.15% $156.33 9.94K Feb 8, 2024 Direct F2
holding JNJ Common Stock 700 Feb 8, 2024 By 401k F3
holding JNJ Common Stock 46 Feb 8, 2024 By ESOP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -1.96K -100% $0.00* 0 Feb 8, 2024 Common Stock 1.96K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
F4 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).